Study: Switching to ENDS Reduces Health Risks Associated With Smoke Exposure

Innovation
Jul.18.2022
A recent study published in NIH found that electronic nicotine delivery systems (ENDS) seem to cause less bronchial epithelial cells toxicity in comparison to cigarettes.

Titled, “Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project,” the study aimed to replicate three published studies looking and comparing the cytotoxic and inflammatory effects of cigarette smoke and ENDS aerosol, in an independent multi-center ring study.

Study: Switching to ENDS Reduces Health Risks Associated With Smoke Exposure

 

The research team established the reliability of results and the robustness of conclusions by replicating the authors’ experimental protocols and then also validating via different methods. After human bronchial epithelial cells (NCI-H292) were exposed to cigarette smoke and e-cig vapour, the researchers assessed the inflammatory cytokines interleukin-6 and interleukin-8 and the remodeling mediator matrix metalloproteinase-1.

 

The researchers confirmed that almost 80% of cytotoxic effects are due to volatile compounds in the vapor phase of smoke. To this effect, they confirmed the reduced cytotoxic effects of ENDS aerosol. However, the data gathered on inflammatory and remodeling activity triggered by smoke differed significantly from those in the original reports. Considering the independent data gathered from multiple laboratories, the study confirmed the reduced toxicity of ENDS compared to cigarettes.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

 

Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes
Malaysia moves ahead with vape sales ban plan; PMI urges Japan-style differentiated excise taxes
Malaysia plans to implement a ban or restrictions on e-cigarettes and vaping products as early as mid-2026 and no later than year-end. The head of Philip Morris Malaysia and Singapore said the government should look to Japan’s approach of regulating and taxing different tobacco and nicotine products differently, warning that an outright ban could push demand into illicit channels.
Feb.02
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan will roll out two new VELO nicotine pouch variants from Feb. 2, 2026: Smooth Peppermint Medium and Breezy Mango Intense. The products will be sold via the official glo & VELO online store, the glo Store Ginza and nationwide tobacco retail channels in Japan.
Jan.23 by 2FIRSTS.ai
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
JTI reshuffles regional leadership; Gabriella Offeddu to lead Romania, Moldova and Bulgaria
JTI reshuffles regional leadership; Gabriella Offeddu to lead Romania, Moldova and Bulgaria
Japan Tobacco International (JTI) has appointed Gabriella Offeddu as general manager for Romania, Moldova and Bulgaria, effective January 2026.
Jan.22 by 2FIRSTS.ai
Georgia Lawmakers Push School Safety Bills Targeting Phones, Vaping and Firearm Safety Education
Georgia Lawmakers Push School Safety Bills Targeting Phones, Vaping and Firearm Safety Education
Georgia lawmakers are weighing new education bills that would tighten classroom phone rules, introduce firearm safety education from an early age, and require vape detectors in all high schools. Supporters argue the measures are needed to address mounting concerns around student safety, mental health and the growing presence of vaping on campuses.
Jan.26 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai